Jiandong Gao

551 total citations
28 papers, 412 citations indexed

About

Jiandong Gao is a scholar working on Nephrology, Molecular Biology and Pharmacology. According to data from OpenAlex, Jiandong Gao has authored 28 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 11 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Jiandong Gao's work include Gout, Hyperuricemia, Uric Acid (11 papers), Pharmacological Effects of Natural Compounds (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Jiandong Gao is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (11 papers), Pharmacological Effects of Natural Compounds (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Jiandong Gao collaborates with scholars based in China and United States. Jiandong Gao's co-authors include HE Li-qun, Michihiro Mitobe, Xiaoli Xie, Georgia I. Anyatonwu, Sorin V. Fedeles, Maria D. Lalioti, Anna‐Rachel Gallagher, Tamehito Onoe, Yiqiang Cai and Barbara E. Ehrlich and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and Journal of Ethnopharmacology.

In The Last Decade

Jiandong Gao

27 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiandong Gao China 11 202 115 109 74 40 28 412
Jingyao Liu China 14 165 0.8× 29 0.3× 33 0.3× 38 0.5× 49 1.2× 33 511
Martin Schepelmann Austria 13 160 0.8× 39 0.3× 81 0.7× 60 0.8× 48 1.2× 25 408
Eiji Takeda Japan 11 208 1.0× 56 0.5× 48 0.4× 60 0.8× 93 2.3× 35 588
Ashok Patel United Kingdom 13 103 0.5× 60 0.5× 55 0.5× 37 0.5× 66 1.6× 22 472
Megan R. Beggs Canada 15 145 0.7× 34 0.3× 104 1.0× 69 0.9× 44 1.1× 26 460
Moko Zeniya Japan 14 432 2.1× 28 0.2× 67 0.6× 15 0.2× 72 1.8× 22 607
Juraj Rievaj United Kingdom 12 237 1.2× 47 0.4× 44 0.4× 31 0.4× 223 5.6× 15 670
Emma T. B. Olesen Denmark 11 411 2.0× 48 0.4× 83 0.8× 26 0.4× 50 1.3× 13 550
Marya Morevati Denmark 13 222 1.1× 34 0.3× 112 1.0× 33 0.4× 30 0.8× 19 498

Countries citing papers authored by Jiandong Gao

Since Specialization
Citations

This map shows the geographic impact of Jiandong Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiandong Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiandong Gao more than expected).

Fields of papers citing papers by Jiandong Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiandong Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiandong Gao. The network helps show where Jiandong Gao may publish in the future.

Co-authorship network of co-authors of Jiandong Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiandong Gao. A scholar is included among the top collaborators of Jiandong Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiandong Gao. Jiandong Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Lan, Tianying, Dongsheng Yao, Feng Wu, et al.. (2023). Effects of resveratrol on renal ischemia-reperfusion injury: A systematic review and meta-analysis. Frontiers in Nutrition. 9. 1064507–1064507. 9 indexed citations
5.
Wang, Chuanxu, et al.. (2023). Shizhifang ameliorates pyroptosis of renal tubular epithelial cells in hyperuricemia through inhibiting NLRP3 inflammasome. Journal of Ethnopharmacology. 317. 116777–116777. 18 indexed citations
7.
Lu, Lili, et al.. (2022). Minimal change disease caused by polycythemia vera: A case report. World Journal of Clinical Cases. 10(32). 11993–11999. 1 indexed citations
8.
Li, Xu, et al.. (2021). Traditional Chinese Herbal Medicine Plays a Role in the Liver, Kidney, and Intestine to Ameliorate Hyperuricemia according to Experimental Studies. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 15 indexed citations
9.
Liu, Weiwei, Qiang Wan, Di Huang, et al.. (2021). Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway. Biomedicine & Pharmacotherapy. 142. 111907–111907. 13 indexed citations
10.
Gao, Jiandong, Guifang Zhao, Pengfei Wang, et al.. (2021). Parecoxib protects against myocardial ischemia/reperfusion via targeting PKA-CREB signaling pathway. Panminerva Medica. 64(4). 587–588. 1 indexed citations
11.
Li, Dongdong, et al.. (2021). Reactive oxygen species induced by uric acid promote NRK‑52E cell apoptosis through the NEK7‑NLRP3 signaling pathway. Molecular Medicine Reports. 24(4). 16 indexed citations
12.
Huang, Di, et al.. (2020). Nod2 silencing is involved in the protective role of Calycosin in diabetic nephropathy cell model. Biocell. 44(2). 1 indexed citations
13.
Xu, Lin, Jiandong Gao, Di Huang, et al.. (2020). Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2. Biochemical and Biophysical Research Communications. 534. 279–285. 26 indexed citations
15.
Wan, Qiang, et al.. (2019). Siwu Granules and Erythropoietin Synergistically Ameliorated Anemia in Adenine-Induced Chronic Renal Failure Rats. Evidence-based Complementary and Alternative Medicine. 2019. 1–12. 10 indexed citations
16.
Gao, Jiandong, Zhihua Sun, Zhaoyang Xiao, et al.. (2019). Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. British Journal of Anaesthesia. 123(6). 827–838. 69 indexed citations
17.
Wan, Qiang, et al.. (2018). Effect and Mechanism of ShiZhiFang on Uric Acid Metabolism in Hyperuricemic Rats. Evidence-based Complementary and Alternative Medicine. 2018(1). 6821387–6821387. 14 indexed citations
18.
He, Fei, Huiling Wang, Qiang Wan, et al.. (2017). Effects of Shizhifang on NLRP3 Inflammasome Activation and Renal Tubular Injury in Hyperuricemic Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 7674240–7674240. 15 indexed citations
19.
Li-qun, HE, et al.. (2015). Icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cells. BMC Complementary and Alternative Medicine. 15(1). 378–378. 17 indexed citations
20.
Li-qun, HE, et al.. (2013). [The research on xiaochalhu decoction improving the inflammation of chronic glomerulonephritis patients and relieving the proteinuria].. PubMed. 33(1). 21–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026